News

Bio-Path Holdings Set to Reveal Third Quarter Financials

Bio-Path Holdings Set to Reveal Third Quarter Financials

Upcoming Announcement from Bio-Path Holdings

HOUSTON — Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneering biotechnology firm, is gearing up to unveil its financial results for the third quarter. The announcement will take place in a live conference call and audio webcast scheduled for Friday at 8:30 a.m. ET. Investors and stakeholders can look forward to insights into the company’s financial performance and a comprehensive business overview.

How to Join the Conference Call

Individuals interested in participating in the live conference call should dial (844) 481-3014 for domestic calls or (412) 317-1879 for international access. It is advisable to connect at least five minutes ahead of the scheduled start time to avoid any technical delays. Additionally, those who prefer to listen online can access the live audio webcast directly from the Presentations section of Bio-Path's website.

Audio Webcast Availability

An archived version of the webcast will be made available on the company’s website approximately two hours following the conclusion of the event, allowing those who cannot attend live to catch up on the important information shared during the call.

About Bio-Path Holdings, Inc.

Bio-Path is recognized for its innovative DNAbilize® technology, which has led to the development of a promising portfolio of RNAi nanoparticle drugs. These drugs can be delivered through simple intravenous transfusions, making treatment simpler for patients. The company's lead candidate, prexigebersen (BP1001), is currently in a Phase 2 study focusing on blood cancers. This drug specifically targets the Grb2 protein, a critical factor in cancer cell survival and proliferation.

Leading Drug Candidates

Another significant candidate in Bio-Path's development pipeline is BP1001-A, a modified version of prexigebersen, which is being evaluated in a Phase 1/1b study for solid tumors. Furthermore, BP1002, which targets the Bcl-2 protein, is under investigation for its effectiveness against blood cancers and solid tumors such as lymphoma and acute myeloid leukemia. The company is also preparing to file an Investigational New Drug (IND) application for BP1003, a sophisticated antisense oligodeoxynucleotide designed to inhibit the STAT3 protein.

Partnerships and Future Directions

Bio-Path Holdings is making notable strides in the biomedical field, signaling potential partnerships to help accelerate the development and marketing of its drug pipeline. As the demand for efficient cancer therapies continues to grow, Bio-Path's advanced technologies position the company as a key player in oncology treatment advancements.

Contact Information for Further Queries

For inquiries or additional details about the company’s offerings, interested parties can reach out to the Investor Relations team. Will O’Connor from Stern Investor Relations is available at 212-362-1200, or contact Doug Morris directly at Bio-Path Holdings, Inc. at 832-742-1369.

Frequently Asked Questions

What is Bio-Path Holdings known for?

Bio-Path Holdings is a biotechnology company specializing in developing antisense RNAi nanoparticle technologies for cancer treatment.

When is the financial results announcement?

The announcement of the financial results for the third quarter of 2024 is scheduled for November 15, 2024.

How can I access the conference call?

You can join the conference call by calling (844) 481-3014 domestically or (412) 317-1879 internationally.

What are Bio-Path's lead drug candidates?

Bio-Path's lead drug candidates include prexigebersen (BP1001) and BP1002, targeting critical proteins associated with various cancers.

Where can I find more information about Bio-Path?

More information can be found on Bio-Path's official website, providing updates on their projects and initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 3

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Pizza: The Unlikely Symbol of Universal Togetherness

Updated Category News Views 5

Why Pizza Is More Than Just Food They say a slice of pizza can tell a story. Whether it's a late-night snack amongst college buddies or the centerpiece of a family's Friday tradition, pizza unites like few others can. It morphs from a study aid into a tool for togetherness without skipping a beat, much like a chameleon of the food world. And no one understands this better...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 4

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Unraveling GE Vernova's Unique Options Movements and Trends

Updated Category News Views 158

Understanding Recent Options Activity of GE Vernova In the world of finance, unusual movements can signal exciting opportunities. Recently, GE Vernova (NYSE: GEV) has attracted attention due to significant trading activities. An analysis of options trading disclosed a total of 51 distinct trades, indicating robust market involvement. Market Sentiment Revealed Diving...

Continue Reading
Corey Robinson Receives Franchisee of the Year Award

Updated Category News Views 107

Batteries Plus Franchisee of the Year Award Recognizes Excellence Corey Robinson, the proud owner of 12 Batteries Plus franchise locations, has recently been celebrated as the Franchisee of the Year by the International Franchise Association (IFA). This honor is reserved for franchise owners who exemplify outstanding achievement in business and community engagement....

Continue Reading
Navigating LNG Approval Challenges Under Trump's Leadership

Updated Category News Views 193

Trump's LNG Export Strategies in Focus By Jarrett Renshaw and Timothy Gardner The advisers to U.S. President-elect Donald Trump are currently emphasizing the importance of a thoughtful approach towards reviving approvals for liquefied natural gas (LNG) export licenses. This cautious stance emerges from concerns that accelerated approvals could face significant challenges...

Continue Reading
Spectris' Trading Update Suggests Strong 2024 Performance Ahead

Updated Category News Views 225

Spectris Shares Rally Following Positive Trading Update Investors are buzzing with excitement as shares in Spectris Plc (LON: SXS) experienced a remarkable surge, climbing over 10% during recent trading sessions in London. This enthusiastic response follows the company’s release of a trading update, indicating an optimistic forecast for the upcoming fiscal year....

Continue Reading
Seneca Foods Shows Growth Amidst Margin Challenges

Updated Category News Views 167

Seneca Foods Corporation's Quarterly Performance Review Seneca Foods Corporation (NASDAQ: SENEA, SENEB) has released its financial results for the most recent quarter and the nine months leading up to December 28, 2024. This report reflects an overall growth in sales alongside formidable challenges in maintaining profit margins. Financial Summary Over the nine-month...

Continue Reading